Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa
dc.contributor.author | Sinanovic, E | |
dc.contributor.author | Ramma, L | |
dc.contributor.author | Vassall, A | |
dc.contributor.author | Azevedo, V | |
dc.contributor.author | Wilkinson, L | |
dc.contributor.author | Ndjeka, N | |
dc.contributor.author | McCarthy, K | |
dc.contributor.author | Churchyard, G | |
dc.contributor.author | Cox, H | |
dc.date.accessioned | 2015-01-27T17:56:54Z | |
dc.date.available | 2015-01-27T17:56:54Z | |
dc.date.issued | 2015-02-01 | |
dc.identifier.citation | Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa. 2015, 19 (2):172-8 Int. J. Tuberc. Lung Dis. | en_GB |
dc.identifier.issn | 1815-7920 | |
dc.identifier.pmid | 25574915 | |
dc.identifier.doi | 10.5588/ijtld.14.0421 | |
dc.identifier.uri | http://hdl.handle.net/10144/338919 | |
dc.description.abstract | The cost of multidrug-resistant tuberculosis (MDR-TB) treatment is a major barrier to treatment scale-up in South Africa. | |
dc.language.iso | en | en |
dc.publisher | International Union Against Tuberculosis and Lung Disease | en_GB |
dc.rights | Archived with thanks to The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease | en_GB |
dc.title | Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa | en |
dc.identifier.journal | International Journal of Tuberculosis and Lung Disease | en_GB |
refterms.dateFOA | 2019-03-04T11:45:10Z | |
html.description.abstract | The cost of multidrug-resistant tuberculosis (MDR-TB) treatment is a major barrier to treatment scale-up in South Africa. |